Soluble ST2 biomarker utility in the comprehension of the clinical course of atrial fibrillation

25 August 2023 (07:30 - 18:30)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Laila Gonzalez-Melchor

Hospital Doctor Jose Molina Orosa, Arrecife, Las Palmas (Spain)

7 More presentations in this session

Presentation thumbnail

Changes in ubiquitylated proteins in atrial fibrillation associated with heart valve disease: proteomics in human left appendage tissue

Doctor Y. Xiao (Changsha, CN)

Abstract Slides Video

Presentation thumbnail

Clonal hematopoiesis of indeterminate potential in atrial fibrillation: prevalence and an association with progression

Doctor H. Ahn (Seoul, KR)

Abstract Slides

Presentation thumbnail

Serum magnesium and phosphorus values are lower among patients with paroxysmal atrial fibrillation: insights from the PLACEBO study

Mrs A. Boulmpou (Nijmegen, NL)

Abstract Slides Video

Presentation thumbnail

Local changes in conduction velocity in the left atrium of atrial fibrillation patients undergoing pulmonary vein isolation

Ms I. Meijer (Amsterdam, NL)

Abstract Slides Video

Presentation thumbnail

Snoring and lack of REM sleep is associated with same-day atrial arrhythmias in a cohort of patients with atrial fibrillation: initial results of TriggersAF

Doctor J. Bacevicius (Vilnius, LT)

Abstract Slides Video

Access the full session

Session thumbnail

Pathophysiology and mechanisms of atrial fibrillation

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023

You may be interested in

Congress Session

Treatment strategies for atrial fibrillation in heart failure

Congress Presentation

Atrial arrhythmias

Congress Session

Basic science and arrhythmia pathophysiology

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources